Flavin-dependent quinone reductases

Cellular and Molecular Life Sciences

Volumn 65, Issue 1, 2008, Pages 141-160

  Deller, S ^a   Macheroux, P ^a   Sollner, S ^a  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Detoxication; Flavodoxin fold; Hydroquinone; Proteasome; Reactive oxygen species; Redox cycling; Semiquinone; Transcription factor

Indexed keywords

5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE; 7,8 DIHYDROXYFLAVONE; BENZO[A]PYRENE; CHLOROQUINE; CHRYSIN; CIBACRON BLUE F3GA; DICOUMAROL; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; FLAVODOXIN; HYDROQUINONE; MEPACRINE; NITROGEN DERIVATIVE; PRODRUG; PROTEIN P53; QUERCETIN; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RESVERATROL; SEMIQUINONE; WARFARIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL TRANSFORMATION; ELECTRON; ENZYME SPECIFICITY; ENZYME STRUCTURE; ESCHERICHIA COLI; EUKARYOTIC CELL; HUMAN; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; FLAVINS; HUMANS; OXIDATIVE STRESS; QUINONE REDUCTASES; TRANSCRIPTION FACTORS;

EUKARYOTA; MAMMALIA;

EID: 38549093144     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7300-y     Document Type: Review

References (117)

1. Ernster, L., Estabrook, R. W., Hochstein, P. and Orrenius, S. (1987) DT-diaphorase, a quinone reductase with special functions in cell metabolism and detoxication. Chem. Scr. 27A, 1-207.
2. Vasiliou, V., Ross, D. and Nebert, D. W. (2006) Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum. Genom. 2, 329-335.
3. Ernster, L. and Narazio, F. (1958) Soluble diaphorase in animal tissue. Acta Chem. Scand. 12, 595-602.
4. Bianchet, M. A., Faig, M. and Amzel, L. M. (2004) Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO). Methods Enzymol. 382, 144-174.
5. Amzel, L. M., Bryant, S. H., Prochaska, H. J. and Talalay, P. (1986) Preliminary crystallographic X-ray data for an NAD(P)H:quinone reductase from mouse liver. J. Biol. Chem. 261, 1379.
6. Ysern, X. and Prochaska, H. J. (1989) X-ray diffraction analyses of crystals of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase containing cibacron blue. J. Biol. Chem. 264, 7765-7767.
7. Li, R., Bianchet, M. A., Talalay, P. and Amzel, L. M. (1995) The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc. Natl. Acad. Sci. USA 92, 8846-8850.
8. Chen, S., Deng, P. S., Bailey, J. M. and Swiderek, K. M. (1994) A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase. Protein Sci. 3, 51-57.
9. Foster, C. E., Bianchet, M. A., Talalay, P., Zhao, Q. and Amzel, L. M. (1999) Crystal structure of human quinone reductase type 2, a metalloflavoprotein. Biochemistry 38, 9881-9886.
10. Vella, F., Ferry, G., Delagrange, P. and Boutin, J. A. (2005) NRH:quinone reductase 2: an enzyme of surprises and mysteries. Biochem. Pharmacol. 71, 1-12.
11. Kwiek, J. J., Haystead, T. A. and Rudolph, J. (2004) Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines. Biochemistry 43, 4538-4547.
12. Liger, D., Graille, M., Zhou, C. Z., Leulliot, N., Quevillon-Cheruel, S., Blondeau, K., Janin, J. and van Tilbeurgh, H. (2004) Crystal structure and functional characterization of yeast YLR011wp, an enzyme with NAD(P)H-FMN and ferric iron reductase activities. J. Biol. Chem. 279, 34890-34897.
13. Dym, O. and Eisenberg, D. (2001) Sequence-structure analysis of FAD-containing proteins. Protein Sci. 10, 1712-1728.
14. Bin, Y., Jiti, Z., Jing, W., Cuihong, D., Hongman, H., Zhiyong, S. and Yongming, B. (2004) Expression and characteristics of the gene encoding azoreductase from Rhodobacter sphaeroides AS1.1737. FEMS Microbiol. Lett. 236, 129-136.
15. Liu, Z. J., Chen, H., Shaw, N., Hopper, S. L., Chen, L., Chen, S., Cerniglia, C. E. and Wang, B. C. (2007) Crystal structure of an aerobic FMN-dependent azoreductase (AzoA) from Enterococcus faecalis. Arch. Biochem. Biophys. 463, 68-77.
16. Sugiura, W., Yoda, T., Matsuba, T., Tanaka, Y. and Suzuki, Y. (2006) Expression and characterization of the genes encoding azoreductases from Bacillus subtilis and Geobacillus stearothermophilus. Biosci. Biotechnol. Biochem. 70, 1655-1665.
17. Suzuki, Y., Yoda, T., Ruhul, A. and Sugiura, W. (2001) Molecular cloning and characterization of the gene coding for azoreductase from Bacillus sp. OY1-2 isolated from soil. J. Biol. Chem. 276, 9059-9065.
18. Patridge, E. V. and Ferry, J. G. (2006) WrbA from Escherichia coli and Archaeoglobus fulgidus is an NAD(P)H:quinone oxidoreductase. J. Bacteriol. 188, 3498-3506.
19. Gorman, J. and Shapiro, L. (2005) Crystal structures of the tryptophan repressor binding protein WrbA and complexes with flavin mononucleotide. Protein Sci. 14, 3004-3012.
20. Grandori, R., Khalifah, P., Boice, J. A., Fairman, R., Giovanielli, K. and Carey, J. (1998) Biochemical characterization of WrbA, founding member of a new family of multimeric flavodoxin-like proteins. J. Biol. Chem. 273, 20960-20966.
21. Zenno, S., Koike, H., Tanokura, M. and Saigo, K. (1996) Gene cloning, purification, and characterization of NfsB, a minor oxygen-insensitive nitroreductase from Escherichia coli, similar in biochemical properties to FRase I, the major flavin reductase in Vibrio fischeri. J. Biochem. (Tokyo) 120, 736-744.
22. Inouye, S. (1994) NAD(P)H-flavin oxidoreductase from the bioluminescent bacterium, Vibrio fischeri ATCC 7744, is a flavoprotein. FEBS Lett. 347, 163-168.
23. Koike, H., Sasaki, H., Kobori, T., Zenno, S., Saigo, K., Murphy, M. E. P., Adman, E. T. and Tanokura, M. (1998) 1.8 Å crystal structure of the major NAD(P)H:FMN oxidoreductase of a bioluminescent bacterium, Vibrio fischeri: overall structure, cofactor and substrate-analog binding, and comparison with related flavoproteins. J. Mol. Biol. 280, 259-273.
24. Ackerley, D. F., Gonzalez, C. F., Park, C. H., Blake, R., 2nd, Keyhan, M. and Matin, A. (2004) Chromate-reducing properties of soluble flavoproteins from Pseudomonas putida and Escherichia coli. Appl. Environ. Microbiol. 70, 873-882.
25. Park, C. H., Keyhan, M., Wielinga, B., Fendorf, S. and Matin, A. (2000) Purification to homogeneity and characterization of a novel Pseudomonas putida chromate reductase. Appl. Environ. Microbiol. 66, 1788-1795.
26. 2. J. Biol. Chem. 280, 22590-22595.
27. Foster, C. E., Bianchet, M. A., Talalay, P., Faig, M. and Amzel, L. M. (2000) Structures of mammalian cytosolic quinone reductases. Free Radic. Biol. Med. 29, 241-245.
28. Deller, S., Sollner, S., Trenker-El-Toukhy, R., Jelesarov, I., Gubitz, G. M. and Macheroux, P. (2006) Characterization of a thermostable NADPH:FMN oxidoreductase from the mesophilic bacterium Bacillus subtilis. Biochemistry 45, 7083-7091.
29. Chen, H., Hopper, S. L. and Cerniglia, C. E. (2005) Biochemical and molecular characterization of an azoreductase from Staphylococcus aureus, a tetrameric NADPH-dependent flavoprotein. Microbiology 151, 1433-1441.
30. Natalello, A., Doglia, S. M., Carey, J. and Grandori, R. (2007) Role of flavin mononucleotide in the thermostability and oligomerization of Escherichia coli stress-defense protein WrbA. Biochemistry 46, 543-553.
31. Sancho, J. (2006) Flavodoxins: sequence, folding, binding, function and beyond. Cell. Mol. Life Sci. 63, 855-864.
32. Tedeschi, G., Chen, S. and Massey, V. (1995) DT-diaphorase: redox potential, steady-state, and rapid reaction studies. J. Biol. Chem. 270, 1198-1204.
33. Lee, C. P., Simard-Duquesne, N., Ernster, L. and Hoberman, H. D. (1965) Stereochemistry of hydrogen-transfer in the energy-linked pyridine nucleotide transhydrogenase and related reactions. Biochim. Biophys. Acta 105, 397-409.
34. Faig, M., Bianchet, M. A., Talalay, P., Chen, S., Winski, S., Ross, D. and Amzel, L. M. (2000) Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release. Proc. Natl. Acad. Sci. USA 97, 3177-3182.
35. Zhou, Z., Fisher, D., Spidel, J., Greenfield, J., Patson, B., Fazal, A., Wigal, C., Moe, O. A. and Madura, J. D. (2003) Kinetic and docking studies of the interaction of quinones with the quinone reductase active site. Biochemistry 42, 1985-1994.
36. Sollner, S., Nebauer, R., Ehammer, H., Prem, A., Deller, S., Palfey, B. A., Daum, G. and Macheroux, P. (2007) Lot6p from Saccharomyces cerevisiae is a FMN-dependent reductase with a potential role in quinone detoxification. Febs J. 274, 1328-1339.
37. Iyanagi, T. and Yamazaki, I. (1970) One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase). Biochim. Biophys. Acta 216, 282-294.
38. Tedeschi, G., Chen, S. and Massey, V. (1995) Active site studies of DT-diaphorase employing artificial flavins. J. Biol. Chem. 270, 2512-2516.
39. Mazoch, J., Tesarik, R., Sedlacek, V., Kucera, I. and Turanek, J. (2004) Isolation and biochemical characterization of two soluble iron(III) reductases from Paracoccus denitrificans. Eur. J. Biochem. 271, 553-562.
40. Morokutti, A., Lyskowski, A., Sollner, S., Pointner, E., Fitzpatrick, T. B., Kratky, C., Gruber, K. and Macheroux, P. (2005) Structure and function of YcnD from Bacillus subtilis, a flavin-containing oxidoreductase. Biochemistry 44, 13724-13733.
41. Chen, H., Wang, R. F. and Cerniglia, C. E. (2004) Molecular cloning, overexpression, purification, and characterization of an aerobic FMN-dependent azoreductase from Enterococcus faecalis. Protein Expr. Purif. 34, 302-310.
42. Jaiswal, A. K. (1994) Human NAD(P)H:quinone oxidoreductase2: gene structure, activity, and tissue-specific expression. J. Biol. Chem. 269, 14502-14508.
43. Powis, G., See, K. L., Santone, K. S., Melder, D. C. and Hodnett, E. M. (1987) Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity. Biochem. Pharmacol. 36, 2473-2479.
44. Boland, M. P., Knox, R. J. and Roberts, J. J. (1991) The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). Biochem. Pharmacol. 41, 867-875.
45. Chen, S., Wu, K. and Knox, R. (2000) Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2). Free Radic. Biol. Med. 29, 276-284.
46. Benson, A. M., Hunkeler, M. J. and Talalay, P. (1980) Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA 77, 5216-5220.
47. Huggins, C. and Fukunishi, R. (1964) Induced protection of adrenal cortex against 7,12-dimethylbenz(alpha)anthracene. Influence of ethionine. Induction of menadione reductase. Incorporation of thymidine-H3. J. Exp. Med. 119, 923-942.
48. Rauth, A. M., Goldberg, Z. and Misra, V. (1997) DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Oncol. Res. 9, 339-349.
49. Nakanishi, M., Yatome, C., Ishida, N. and Kitade, Y. (2001) Putative ACP phosphodiesterase gene (acpD) encodes an azoreductase. J. Biol. Chem. 276, 46394-46399.
50. Wallin, R., Gebhardt, O. and Prydz, H. (1978) NAD(P)H dehydrogenase and its role in the vitamin K (2-methyl-3-phytyl-1,4-naphthaquinone)-dependent carboxylation reaction. Biochem. J. 169, 95-101.
51. Hollander, P. M. and Ernster, L. (1975) Studies on the reaction mechanism of DT diaphorase: action of dead-end inhibitors and effects of phospholipids. Arch. Biochem. Biophys. 169, 560-567.
52. Chen, S., Wu, K., Zhang, D., Sherman, M., Knox, R. and Yang, C. S. (1999) Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling. Mol. Pharmacol. 56, 272-278.
53. Zhao, Q., Yang, X. L., Holtzclaw, W. D. and Talalay, P. (1997) Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase). Proc. Natl. Acad. Sci. USA 94, 1669-1674.
54. Barret, J. M., Ernould, A. P., Ferry, G., Genton, A. and Boutin, J. A. (1993) Integrated system for the screening of the specificity of protein kinase inhibitors. Biochem. Pharmacol. 46, 439-448.
55. Boutin, J. A., Chatelain-Egger, F., Vella, F., Delagrange, P. and Ferry, G. (2005) Quinone reductase 2 substrate specificity and inhibition pharmacology. Chem. Biol. Interact. 151, 213-228.
56. Buryanovskyy, L., Fu, Y., Boyd, M., Ma, Y., Hsieh, T. C., Wu, J. M. and Zhang, Z. (2004) Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43, 11417-11426.
57. Graves, P. R., Kwiek, J. J., Fadden, P., Ray, R., Hardeman, K., Coley, A. M., Foley, M. and Haystead, T. A. (2002) Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol. Pharmacol. 62, 1364-1372.
58. Chesis, P. L., Levin, D. E., Smith, M. T., Ernster, L. and Ames, B. N. (1984) Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc. Natl. Acad. Sci. USA 81, 1696-1700.
59. Schuetzle, D., Siegl, W. O., Jensen, T. E., Dearth, M. A., Kaiser, E. W., Gorse, R., Kreucher, W. and Kulik, E. (1994) The relationship between gasoline composition and vehicle hydrocarbon emissions: a review of current studies and future research needs. Environ Health Perspect. 102 (suppl. 4), 3-12.
60. Brunmark, A. and Cadenas, E. (1989) Redox and addition chemistry of quinoid compounds and its biological implications. Free Radic. Biol. Med. 7, 435-477.
61. Maerki, F. and Martius, C. (1960) Vitamin K reductase, preparation and properties. Biochem. Z. 333, 111-135.
62. Dinkova-Kostova, A. T. and Talalay, P. (2000) Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radic. Biol. Med. 29, 231-240.
63. Williams-Ashman, H. G. and Huggins, C. (1961) Oxydation of reduced pyridine nucleotides in mammary gland and adipose tissue following treatment with polynuclear hydrocarbons. Med. Exp. Int. J. Exp. Med. 4, 223-226.
64. Wattenberg, L. W. (1978) Inhibitors of chemical carcinogenesis. Adv. Cancer Res. 26, 197-226.
65. Benson, A. M., Batzinger, R. P., Ou, S. Y., Bueding, E., Cha, Y. N. and Talalay, P. (1978) Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res. 38, 4486-4495.
66. Prochaska, H. J., Talalay, P. and Sies, H. (1987) Direct protective effect of NAD(P)H:quinone reductase against menadione-induced chemiluminescence of postmitochondrial fractions of mouse liver. J. Biol. Chem. 262, 1931-1934.
67. Thor, H., Smith, M. T., Hartzell, P., Bellomo, G., Jewell, S. A. and Orrenius, S. (1982) The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes: a study of the implications of oxidative stress in intact cells. J. Biol. Chem. 257, 12419-12425.
68. Munday, R., Smith, B. L. and Munday, C. M. (1998) Effects of butylated hydroxyanisole and dicoumarol on the toxicity of menadione to rats. Chem. Biol. Interact. 108, 155-170.
69. Iskander, K. and Jaiswal, A. K. (2005) Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity. Chem. Biol. Interact. 153-154, 147-157.
70. Palming, J., Sjöholm, K., Jernås, M., Lystig, T. C., Gummesson, A., Romeo, S., Lönn, L., Lönn, M., Carlsson, B., and Carlsson, L. M. (2007) The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss and correlates to adiposity, insulin sensitivity and markers of liver dysfunction. J. Clin. Endocrinol. Metab.
71. Lind, C., Hochstein, P. and Ernster, L. (1982) DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation. Arch. Biochem. Biophys. 216, 178-185.
72. Radjendirane, V. and Jaiswal, A. K. (1999) Coordinated induction of the c-jun gene with genes encoding quinone oxidoreductases in response to xenobiotics and antioxidants. Biochem. Pharmacol. 58, 597-603.
73. Jaiswal, A. K., Burnett, P., Adesnik, M. and McBride, O. W. (1990) Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family: extensive polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry 29, 1899-1906.
74. Harada, S., Fujii, C., Hayashi, A. and Ohkoshi, N. (2001) An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem. Biophys. Res. Commun. 288, 887-892.
75. Harada, S., Tachikawa, H. and Kawanishi, Y. (2003) A possible association between an insertion/deletion polymorphism of the NQO2 gene and schizophrenia. Psychiatr. Genet. 13, 205-209.
76. Wang, W. and Jaiswal, A. K. (2004) Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter. Free Radic. Biol. Med. 37, 1231-1243.
77. Strassburg, A., Strassburg, C. P., Manns, M. P. and Tukey, R. H. (2002) Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue. Mol. Pharmacol. 61, 320-325.
78. Beyer, R. E. (1994) The relative essentiality of the antioxidative function of coenzyme Q - the interactive role of DT-diaphorase. Mol. Aspects Med. 15 (suppl.) s117-s129.
79. Beyer, R. E., Segura-Aguilar, J., Di Bernardo, S., Cavazzoni, M., Fato, R., Fiorentini, D., Galli, M. C., Setti, M., Landi, L., and Lenaz, G. (1996) The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc. Natl. Acad. Sci. USA 93, 2528-2532.
80. Siegel, D., Bolton, E. M., Burr, J. A., Liebler, D. C. and Ross, D. (1997) The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant. Mol. Pharmacol. 52, 300-305.
81. Wang, G., Alamuri, P. and Maier, R. J. (2006) The diverse antioxidant systems of Helicobacter pylori. Mol. Microbiol. 61, 847-860.
82. Wang, G. and Maier, R. J. (2004) An NADPH quinone reductase of Helicobacter pylori plays an important role in oxidative stress resistance and host colonization. Infect. Immun. 72, 1391-1396.
83. Ross, D. and Siegel, D. (2004) NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol. 382, 115-144.
84. Wang, T., Arifoglu, P., Ronai, Z. and Tew, K. D. (2001) Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J. Biol. Chem. 276, 20999-21003.
85. Asher, G., Lotem, J., Kama, R., Sachs, L. and Shaul, Y. (2002) NQO1 stabilizes p53 through a distinct pathway. Proc. Natl. Acad. Sci. USA 99, 3099-3104.
86. Oren, M. (1992) p53: the ultimate tumor suppressor gene? Faseb J. 6, 3169-3176.
87. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W. and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature 389, 300-305.
88. Asher, G., Lotem, J., Cohen, B., Sachs, L. and Shaul, Y. (2001) Regulation of p53 stability and p53-dependent apoptosis by NADHquinone oxidoreductase 1. Proc. Natl. Acad. Sci. USA 98, 1188-1193.
89. Lafuente, M. J., Casterad, X., Trias, M., Ascaso, C., Molina, R., Ballesta, A., Zheng, S., Wiencke, J. K., and Lafuente, A. (2000) NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis 21, 1813-1819.
90. Long, D. J., 2nd, Waikel, R. L., Wang, X. J., Roop, D. R. and Jaiswal, A. K. (2001) NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz-[a]-anthracene-induced carcinogenesis in mouse skin. J. Natl. Cancer. Inst. 93, 1166-1170.
91. Asher, G., Lotem, J., Sachs, L., Kahana, C. and Shaul, Y. (2002) Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc. Natl. Acad. Sci. USA 99, 13125-13130.
92. Anwar, A., Dehn, D., Siegel, D., Kepa, J. K., Tang, L. J., Pietenpol, J. A. and Ross, D. (2003) Interaction of human NAD(P)H:quinone oxidoreductase 1(NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J. Biol. Chem. 278, 10368-10373.
93. Asher, G., Tsvetkov, P., Kahana, C. and Shaul, Y. (2005) A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 19, 316-321.
94. Asher, G. and Shaul, Y. (2005) p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle 4, 1015-1018.
95. Luster, D. G. and Buckhout, T. J. (1989) Purification and identification of a plasma membrane associated electron transport protein from maize (Zea mays L.) roots. Plant Physiol. 91, 1014-1019.
96. Serrano, A., Cordoba, F. , Gonzalez-Reyes, J. A. , Navas, P. and Villalba, J. M. (1994) Purification and characterization of two distinct NAD(P)H dehydrogenases from onion (Allium cepa L.) root plasma membrane. Plant Physiol. 106, 87-96.
97. Trost, P., Foscarini, S., Preger, V., Bonora, P., Vitale, L. and Pupillo, P. (1997) Dissecting the diphenylene iodonium-sensitive NAD(P)H:quinone oxidoreductase of zucchini plasma membrane. Plant Physiol. 114, 737-746.
98. Brock, B. J. and Gold, M. H. (1996) 1,4-Benzoquinone reductase from basidiomycete Phanerochaete chrysosporium: spectral and kinetic analysis. Arch. Biochem. Biophys. 331, 31-40.
99. Sparla, F., Tedeschi, G., Pupillo, P. and Trost, P. (1999) Cloning and heterologous expression of NAD(P)H:quinone reductase of Arabidopsis thaliana, a functional homologue of animal DT-diaphorase. FEBS Lett. 463, 382-386.
100. Sparla, F., Tedeschi, G. and Trost, P. (1996) NAD(P)H:(quinone-acceptor) oxidoreductase of tobacco leaves is a flavin mononucleotide-containing flavoenzyme. Plant Physiol. 112, 249-258.
101. Trost, P., Bonora, P., Scagliarini, S. and Pupillo, P. (1995) Purification and properties of NAD(P)H:(quinone-acceptor) oxidoreductase of sugarbeet cells. Eur. J. Biochem. 234, 452-458.
102. Harborne, J. B. (1980) Plant phenolics. In: Encyclopedia Plant Physiology (Bell, E. A. and Charlwood, B. V., eds), pp. 329-395. Springer, Berlin
103. Chareonthiphakorn, N., Wititsuwannakul, D., Golan-Goldhirsh, A. and Wititsuwannakul, R. (2002) Purification and characterization of NAD(P)H quinone reductase from the latex of Hevea brasiliensis Mull.-Arg. (Euphorbiaceae). Phytochemistry 61, 123-128.
104. Laskowski, M. J. , Dreher, K. A., Gehring, M. A. , Abel, S. , Gensler, A. L. and Sussex, I. M. (2002) FQR1, a novel primary auxin-response gene, encodes a flavin mononucleotide-binding quinone reductase. Plant Physiol. 128, 578-590.
105. Matvienko, M., Wojtowicz, A., Wrobel, R., Jamison, D., Goldwasser, Y. and Yoder, J. I. (2001) Quinone oxidoreductase message levels are differentially regulated in parasitic and non-parasitic plants exposed to allelopathic quinones. Plant J. 25, 375-387.
106. Greenshields, D. L., Liu, G., Selvaraj, G. and Wei, Y. (2005) Differential regulation of wheat quinone reductases in response to powdery mildew infection. Planta 222, 867-875.
107. Knox, R. J. and Chen, S. (2004) Quinone reductase-mediated nitro-reduction: clinical applications. Methods Enzymol. 382, 194-221.
108. Connors, T. A. (1995) The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther. 2, 702-709.
109. Connors, T. A. and Whisson, M. E. (1966) Cure of mice bearing advanced plasma cell tumours with aniline mustard: the relationship between glucuronidase activity and tumour sensitivity. Nature 210, 866-867.
110. Jaiswal, A. K. (2000) Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic. Biol. Med. 29, 254-262.
111. Schor, N. A. and Cornelisse, C. J. (1983) Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colonic carcinomas. Cancer Res. 43, 4850-4855.
112. Siegel, D. and Ross, D. (2000) Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic. Biol. Med. 29, 246-253.
113. Siegel, D., Ryder, J. and Ross, D. (2001) NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells. Toxicol. Lett. 125, 93-98.
114. Workman, P., Morgan, J. E., Talbot, K., Wright, K. A., Donaldson, J. and Twentyman, P. R. (1986) CB 1954 revisited. II. Toxicity and antitumour activity. Cancer Chemother. Pharmacol. 16, 9-14.
115. Chen, S., Knox, R., Wu, K., Deng, P. S., Zhou, D., Bianchet, M. A. and Amzel, L. M. (1997) Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse. J. Biol. Chem. 272, 1437-1439.
116. Knox, R. J., Jenkins, T. C., Hobbs, S. M., Chen, S., Melton, R. G. and Burke, P. J. (2000) Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Cancer Res. 60, 4179-4186.
117. Brodskii, L. I., Ivanov, V. V., Kalaidzidis Ia, L., Leontovich, A. M., Nikolaev, V. K., Feranchuk, S. I. and Drachev, V. A. (1995) GeneBee-NET: an internet-based server for biopolymer structure analysis. Biokhimiia 60, 1221-1230.